MODULATION OF HEATSHOCK-PROTEIN-BASED IMMUNOTHERAPIES

Details for Australian Patent Application No. 2002365058 (hide)

Owner MOJAVE THERAPEUTICS, INC.

Inventors WIELAND, Felix; HARTL, Franz-Ulrich

Pub. Number AU-A-2002365058

PCT Number PCT/US02/41373

PCT Pub. Number WO2003/062262

Priority 60/343,884 28.12.01 US; 60/372,620 12.04.02 US; 60/399,342 29.07.02 US; 60/414,834 28.09.02 US; 60/342,570 26.12.01 US

Filing date 24 December 2002

Wipo publication date 2 September 2003

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/343,884 28.12.01 US; 60/372,620 12.04.02 US; 60/399,342 29.07.02 US; 60/414,834 28.09.02 US; 60/342,570 26.12.01 US

18 September 2003 Application Open to Public Inspection

  Published as AU-A-2002365058

18 May 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002365059-CATALYTIC DNA SEQUENCES WHICH FACILITATE DNA CLEAVAGE AND RE-LIGATION REACTIONS, DISCOVERED BY UNILATERAL ACTIVATED EXCHANGEABLE DNA

2002365057-COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE